Brazilian company Silimed obtained a favorable ruling from a European court in a dispute involving the technology used to manufacture polyurethane-coated breast implants. The controversy concerns allegations of misappropriation of trade secrets and the unauthorized use of technology developed by the Brazilian company by its German competitor, Polytech. The decision recognized Silimed’s ownership of the technology and may result in multi-billion-dollar damages due to the commercial exploitation of the patent over recent years.

Relevance:

The case represents an important precedent for the international protection of the intellectual property rights of Brazilian companies, particularly in sectors characterized by advanced technology and industrial innovation. The ruling reinforces the effectiveness of legal protection for trade secrets and patents in transnational disputes, while also highlighting the importance of contractual confidentiality mechanisms and technological safeguards in international business partnerships. The judgment is also expected to have a significant economic impact on the global medical device market and on the strategic valuation of intangible assets in the corporate environment.

Source:

VALOR ECONÔMICO. Silimed Prevails in European Court in Patent Dispute. Available at: Valor Econômico.